Compare HAFC & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | HAFC | CBLL |
|---|---|---|
| Founded | 1982 | 2014 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 758.9M | 865.4M |
| IPO Year | N/A | N/A |
| Metric | HAFC | CBLL |
|---|---|---|
| Price | $27.23 | $19.94 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $31.33 | $24.67 |
| AVG Volume (30 Days) | ★ 315.2K | 305.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.65 | $37.44 |
| Revenue Next Year | $7.28 | $27.72 |
| P/E Ratio | $10.88 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.25 | $10.01 |
| 52 Week High | $30.20 | $26.04 |
| Indicator | HAFC | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 46.49 | 43.82 |
| Support Level | $26.36 | $19.49 |
| Resistance Level | $28.43 | $20.72 |
| Average True Range (ATR) | 0.84 | 1.03 |
| MACD | -0.04 | -0.13 |
| Stochastic Oscillator | 54.04 | 37.85 |
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.